BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38331194)

  • 1. Maternal Administration of Busulfan before in Utero Hematopoietic Cell Transplantation Improves Congenic Bone Marrow Cell Engraftment in a Murine Model.
    Shi C; Li Z; Sun Z; Pan L
    Transplant Cell Ther; 2024 Apr; 30(4):398.e1-398.e10. PubMed ID: 38331194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation.
    Ashizuka S; Peranteau WH; Hayashi S; Flake AW
    Exp Hematol; 2006 Mar; 34(3):359-68. PubMed ID: 16543070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-Existing Maternal Antibodies Cause Rapid Prenatal Rejection of Allotransplants in the Mouse Model of In Utero Hematopoietic Cell Transplantation.
    Riley JS; McClain LE; Stratigis JD; Coons BE; Li H; Hartman HA; Peranteau WH
    J Immunol; 2018 Sep; 201(5):1549-1557. PubMed ID: 30021770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.
    Peranteau WH; Endo M; Adibe OO; Merchant A; Zoltick PW; Flake AW
    Blood; 2006 Dec; 108(13):4268-74. PubMed ID: 16954501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
    Down JD; Ploemacher RE
    Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition.
    Kim AG; Vrecenak JD; Boelig MM; Eissenberg L; Rettig MP; Riley JS; Holt MS; Conner MA; Loukogeorgakis SP; Li H; DiPersio JF; Flake AW; Peranteau WH
    Blood; 2016 Nov; 128(20):2457-2461. PubMed ID: 27650329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation.
    Koporc Z; Bigenzahn S; Blaha P; Fariborz E; Selzer E; Sykes M; Muehlbacher F; Wekerle T
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):284-92. PubMed ID: 16503497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.
    Peranteau WH; Heaton TE; Gu YC; Volk SW; Bauer TR; Alcorn K; Tuschong LM; Johnson MP; Hickstein DD; Flake AW
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):293-305. PubMed ID: 19203720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal transplantation of cytokine-stimulated marrow improves early chimerism in a resistant strain combination but results in poor long-term engraftment.
    Shaaban AF; Kim HB; Gaur L; Liechty KW; Flake AW
    Exp Hematol; 2006 Sep; 34(9):1278-87. PubMed ID: 16939821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.
    Peranteau WH; Hayashi S; Abdulmalik O; Chen Q; Merchant A; Asakura T; Flake AW
    Blood; 2015 Sep; 126(10):1245-54. PubMed ID: 26124498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.
    Dighe NM; Tan KW; Tan LG; Shaw SSW; Buckley SMK; Sandikin D; Johana N; Tan YW; Biswas A; Choolani M; Waddington SN; Antoniou MN; Chan JKY; Mattar CNZ
    Exp Hematol; 2018 Jun; 62():45-55. PubMed ID: 29605545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation.
    Vrecenak JD; Pearson EG; Santore MT; Todorow CA; Li H; Radu A; Bhatti T; Peranteau WH; Johnson MP; Flake AW
    Blood; 2014 Sep; 124(12):1987-95. PubMed ID: 24869940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
    Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
    Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.
    Hayashi S; Peranteau WH; Shaaban AF; Flake AW
    Blood; 2002 Aug; 100(3):804-12. PubMed ID: 12130490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero.
    Ihara N; Akihiro U; Onami N; Tsumura H; Inoue E; Hayashi S; Sago H; Mizutani S
    Congenit Anom (Kyoto); 2015 Feb; 55(1):55-64. PubMed ID: 25421592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an immune barrier after in utero hematopoietic-cell transplantation.
    Peranteau WH; Endo M; Adibe OO; Flake AW
    Blood; 2007 Feb; 109(3):1331-3. PubMed ID: 17023584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow.
    Tomita Y; Sachs DH; Sykes M
    Blood; 1994 Feb; 83(4):939-48. PubMed ID: 7906567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment.
    van Os R; Dawes D; Mislow JM; Witsell A; Mauch PM
    Blood; 1997 Apr; 89(7):2376-83. PubMed ID: 9116281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation.
    Peranteau WH; Hayashi S; Hsieh M; Shaaban AF; Flake AW
    Blood; 2002 Sep; 100(6):2225-34. PubMed ID: 12200389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Intravenous Route of Injection Optimizes Engraftment and Survival in the Murine Model of In Utero Hematopoietic Cell Transplantation.
    Boelig MM; Kim AG; Stratigis JD; McClain LE; Li H; Flake AW; Peranteau WH
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):991-999. PubMed ID: 26797401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.